首页> 美国卫生研究院文献>other >Mild Effect of Nalmefene on Alcoholic Cue-Induced Response Invigoration in Alcohol Use Disorder Without Accompanying Changes in Electrophysiological Signatures of Early Visual Processing and Executive Control
【2h】

Mild Effect of Nalmefene on Alcoholic Cue-Induced Response Invigoration in Alcohol Use Disorder Without Accompanying Changes in Electrophysiological Signatures of Early Visual Processing and Executive Control

机译:纳美芬对酒精使用诱发的酒精使用障碍反应诱发的轻度影响但不伴随早期视觉加工和执行控制的电生理特征变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nalmefene is approved for as-needed pharmacological treatment in alcohol use disorder (AUD) by the European Medicines Agency. While the cellular effects of nalmefene have been thoroughly investigated, data are very limited on how this agent influences neural signals associated with inhibitory control and the visual analysis of environmental cues. This double-blind crossover study assessed the behavioral and neural effects of acute nalmefene administration in patients diagnosed with AUD. In experiment 1, we validated our experimental paradigm (electroencephalography combined with a modified Go/NoGo task using images of alcoholic and nonalcoholic drinks as prime stimuli) in 20 healthy adults to ensure that our protocol is suitable for assessing the behavioral and neural aspects of executive control. In experiment 2, we recruited 19 patients with AUD, and in a double-blind crossover design, we investigated the effects of nalmefene versus placebo on task performance (response accuracy, the sensitivity index, and reaction times), visual responses to appetitive cues (occipital P1, N1, and P2 components), and electrophysiological markers of conflict detection and response inhibition (frontal N2 and P3 waveforms). Under placebo, patients produced faster reaction times to alcohol-primed Go stimuli, an effect that was weak despite being statistically significant. However, the effect of alcoholic cues on the speed of response initiation disappeared after receiving nalmefene. We found no placebo versus nalmefene difference regarding our patients’ ability to accurately inhibit responses to NoGo stimuli or for occipital and frontal event-related potentials. Our results suggest that nalmefene might be potent in reducing the vigor to act upon alcoholic cues in AUD patients, but this effect is most probably mediated via subcortical (rather than cortical) neural circuits.
机译:纳美芬已被欧洲药品管理局批准用于酒精使用障碍(AUD)的按需药物治疗。尽管已经对纳美芬的细胞作用进行了彻底研究,但有关该药物如何影响与抑制性控制和环境线索的视觉分析有关的神经信号的数据非常有限。这项双盲交叉研究评估了急性纳美芬在诊断为AUD的患者中的行为和神经作用。在实验1中,我们在20名健康成年人中验证了我们的实验范式(脑电图结合改良的Go / NoGo任务,使用酒精和非酒精饮料的图像作为主要刺激),以确保我们的方案适合评估执行者的行为和神经方面控制。在实验2中,我们招募了19例AUD患者,并在双盲交叉设计中,我们调查了纳美芬与安慰剂对任务绩效(反应准确性,敏感性指数和反应时间),对食欲暗示的视觉反应(枕骨P1,N1和P2组件)以及冲突检测和响应抑制的电生理标记(额叶N2和P3波形)。在安慰剂下,患者对酒精引发的Go刺激产生更快的反应时间,尽管具有统计学意义,但这种作用较弱。然而,接受纳美芬后,酒精提示对反应开始速度的影响消失了。我们没有发现安慰剂与纳美芬在患者准确抑制对NoGo刺激或枕骨和额叶事件相关电位的反应能力方面的差异。我们的研究结果表明,纳美芬可能会有效降低AUD患者酒后暗示的活力,但这种作用很可能是通过皮层下(而非皮层)神经回路介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号